DK2851075T3 - Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat - Google Patents

Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat Download PDF

Info

Publication number
DK2851075T3
DK2851075T3 DK13790955.2T DK13790955T DK2851075T3 DK 2851075 T3 DK2851075 T3 DK 2851075T3 DK 13790955 T DK13790955 T DK 13790955T DK 2851075 T3 DK2851075 T3 DK 2851075T3
Authority
DK
Denmark
Prior art keywords
morphinine
carbamoyl
unsaturated
derivative
preparation containing
Prior art date
Application number
DK13790955.2T
Other languages
English (en)
Inventor
Akira Mashimo
Shunji Ichio
Original Assignee
Shionogi & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi & Co filed Critical Shionogi & Co
Application granted granted Critical
Publication of DK2851075T3 publication Critical patent/DK2851075T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2013Organic compounds, e.g. phospholipids, fats
    • A61K9/2018Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/2027Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DK13790955.2T 2012-05-14 2013-05-13 Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat DK2851075T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012110417 2012-05-14
PCT/JP2013/063278 WO2013172297A1 (ja) 2012-05-14 2013-05-13 6,7-不飽和-7-カルバモイルモルヒナン誘導体含有製剤

Publications (1)

Publication Number Publication Date
DK2851075T3 true DK2851075T3 (da) 2022-01-31

Family

ID=49583702

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13790955.2T DK2851075T3 (da) 2012-05-14 2013-05-13 Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat

Country Status (9)

Country Link
US (3) US10952968B2 (da)
EP (1) EP2851075B1 (da)
JP (1) JP5818219B2 (da)
CA (1) CA2873961C (da)
DK (1) DK2851075T3 (da)
ES (1) ES2903149T3 (da)
PL (1) PL2851075T3 (da)
TW (1) TW201350120A (da)
WO (1) WO2013172297A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110325178B (zh) * 2016-12-26 2022-05-13 盐野义制药株式会社 改善含量均一性的制剂的制造方法
JP6131379B1 (ja) * 2016-12-28 2017-05-17 森下仁丹株式会社 4,5−エポキシモルヒナン誘導体含有製剤
EP4062973A4 (en) * 2019-11-20 2023-11-29 Shionogi & Co., Ltd SOLID FORMULATION CONTAINING 6,7-UNSATURATED-7-CARBAMOYL MORPHINAND DERIVATIVE
WO2021172462A1 (ja) * 2020-02-28 2021-09-02 塩野義製薬株式会社 術後の消化管の回復促進のための医薬組成物および方法

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4365060A (en) * 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
US4931286A (en) * 1989-04-19 1990-06-05 Aqualon Company High gloss cellulose tablet coating
US5225201A (en) * 1991-08-23 1993-07-06 Minnesota Mining And Manufacturing Company Salsalate tablet
US5395627A (en) * 1992-09-04 1995-03-07 Akzo N.V. Pharmaceutical granulate
TW442301B (en) 1995-06-07 2001-06-23 Sanofi Synthelabo Pharmaceutical compositions containing irbesartan
EP1203580A4 (en) * 1999-06-18 2004-06-30 Takeda Chemical Industries Ltd SOLID PREPARATIONS WITH FAST DISINTEGRATION
GB0001621D0 (en) * 2000-01-26 2000-03-15 Astrazeneca Ab Pharmaceutical compositions
CA2350195C (en) 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US20030114527A1 (en) 2001-08-31 2003-06-19 Karnachi Anees Abdulquadar Pharmaceutical composition
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
PA8576201A1 (es) 2002-07-10 2004-05-26 Pfizer Prod Inc Composicion farmaceutica que tiene una distribucion y potencia uniforme de farmaco
WO2004054619A1 (ja) * 2002-12-17 2004-07-01 Wakunaga Pharmaceutical Co., Ltd. 遮光剤及び皮膜組成物
EP1615626B1 (en) * 2003-04-24 2009-10-14 Jagotec Ag Tablet with coloured core
US8168218B2 (en) * 2003-04-24 2012-05-01 Jagotec Ag Delayed release tablet with defined core geometry
BRPI0412523A (pt) 2003-07-11 2006-09-19 Hoffmann La Roche forma de dosagem oral de mesilato de saquinavir
US20080095841A1 (en) 2004-10-06 2008-04-24 Eisai R&D Management Co., Ltd. Pharmaceutical Composition, Method for Producing the Same, and Method for Stabilizing Dihydropyridine Compound in the Pharmaceutical Composition
US20060280789A1 (en) * 2004-12-27 2006-12-14 Eisai Research Institute Sustained release formulations
JP4214128B2 (ja) 2005-04-27 2009-01-28 大日本住友製薬株式会社 光安定性の向上した組成物
WO2006126529A1 (ja) 2005-05-25 2006-11-30 Shionogi & Co., Ltd. 6,7-不飽和-7-カルバモイル置換モルヒナン誘導体
US8637078B2 (en) * 2005-11-24 2014-01-28 Boehringer Ingelheim International Gmbh Bilayer tablet comprising telmisartan and diuretic
JP5432720B2 (ja) * 2007-03-13 2014-03-05 武田薬品工業株式会社 2−[[6−[(3r)−3−アミノ−1−ピペリジニル]−3,4−ジヒドロ−3−メチル−2,4−ジオキソ−1(2h)−ピリミジニル]メチル]−4−フルオロベンゾニトリルを含む固形製剤
EP2151241B1 (en) 2007-04-26 2012-03-21 Toray Industries, Inc. Stable solid preparation comprising 4,5-epoxymorphinan derivative
AU2008254038B2 (en) * 2007-05-21 2013-01-10 Toray Industries, Inc. Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation
EA200901591A1 (ru) * 2007-06-13 2010-06-30 Медитор Фармасьютикалс Лтд. Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
CL2008003230A1 (es) * 2007-11-01 2009-11-27 Sanofi Aventis Healthcare Pty Ltd Composicion de recubrimiento de tableta que comprende polimero celulosico, plastificante, edulcorante y composicion de sabor en polvo la que comprende saborizante asociado con portador solido; fluido de recubrimiento de tableta que comprende dicha composicion; tableta farmaceutica; proceso de preparacion de dicha tableta.
WO2009087690A2 (en) * 2008-01-11 2009-07-16 Jubilant Organosys Limited Multiparticulate extended release pharmaceutical composition of carbamazepine and process for manufacturing the same
WO2009101940A1 (ja) 2008-02-11 2009-08-20 Dainippon Sumitomo Pharma Co., Ltd. 溶出性の改善された錠剤
AR073380A1 (es) * 2008-09-25 2010-11-03 Takeda Pharmaceutical Composicion farmaceutica solida. comprimido multicapa
BRPI0920599B1 (pt) 2008-10-24 2021-10-19 Toray Industries, Inc. Comprimido estável contendo um derivado de 4,5-epoximorfinano
JP5452050B2 (ja) 2009-03-27 2014-03-26 杏林製薬株式会社 イミダフェナシンを含有する口腔内崩壊錠
EP2412370A4 (en) * 2009-03-27 2013-05-22 Kyorin Seiyaku Kk MATRIX-LIKE EXTENDED RELEASE PREPARATION CONTAINING A BASIC ADDITIVE
JP5644167B2 (ja) 2009-04-21 2014-12-24 大正製薬株式会社 溶出改善されたケトチフェン又はその塩を含有する固形製剤
WO2011057222A1 (en) * 2009-11-06 2011-05-12 Infinity Pharmaceuticals, Inc. Oral formulations of a hedgehog pathway inhibitor
JP2011105694A (ja) 2009-11-12 2011-06-02 Takada Seiyaku Kk オロパタジン経口固形組成物
WO2011087705A2 (en) * 2009-12-22 2011-07-21 Fmc Corporation Fine particle croscarmellose and uses thereof
PL2639234T3 (pl) 2010-11-12 2019-12-31 Shionogi & Co., Ltd. Krystaliczna pochodna morfinanu 6,7-nienasyconego-7-karbamoilu i sposób jej wytwarzania
EP2922926A4 (en) * 2012-11-26 2016-07-20 Progel Pty Ltd COATING COMPOSITION

Also Published As

Publication number Publication date
PL2851075T3 (pl) 2022-02-21
ES2903149T3 (es) 2022-03-31
CA2873961A1 (en) 2013-11-21
CA2873961C (en) 2017-09-26
EP2851075B1 (en) 2021-12-01
US11116727B2 (en) 2021-09-14
JPWO2013172297A1 (ja) 2016-01-12
WO2013172297A1 (ja) 2013-11-21
US20190046452A1 (en) 2019-02-14
US20210145753A1 (en) 2021-05-20
TW201350120A (zh) 2013-12-16
JP5818219B2 (ja) 2015-11-18
US20150216804A1 (en) 2015-08-06
EP2851075A1 (en) 2015-03-25
US10952968B2 (en) 2021-03-23
EP2851075A4 (en) 2015-10-21

Similar Documents

Publication Publication Date Title
SMT201700065B (it) Derivato piridonico
DK2890256T3 (da) Nikotinsammensætning
CO6990736A2 (es) Pirrolidina-2-carboxamidas sustituídas
BR112015002738A2 (pt) composto , e , composição farmacêutica
DK3263564T3 (da) Aza-aryl-1h-pyrazol-1-yl-benzen-sulfonamider som ccr(9)- antagonister
BR112014032798A2 (pt) composição
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
UA24760S (uk) Шрифт
CO7020919A2 (es) Derivados de tetrahidro-quinazolinona
FI20135047A (fi) Katseenohjausjärjestely
DK2897594T3 (da) Farmaceutisk sammensætning
DK2804611T3 (da) Chitosanafledte forbindelser
HK1207317A1 (en) Substituted 1,6-naphthyridines 16-
BR112014032712A2 (pt) composição
CL2015001192A1 (es) Composición herbicida
CO7020920A2 (es) Derivado de fenilazol sustituido
DK2851075T3 (da) Præparat, der indeholder 6,7-umættet -7-carbamoylmorphinanderivat
GB201320585D0 (en) Insecticidal compounds based on arylthiosulfonamide derivatives
DK2811828T3 (da) Adjuvanssammensætninger
DE102013212400A8 (de) Abdeckplattenstützbaugruppe
DK2922571T3 (da) Farmaceutiske formuleringer, der omfatter carboran-holdige metallo-porphyriner
DK2800573T3 (da) Oftalmologisk sammensætning
DK2822938T3 (da) Rodenticide norbormidanaloger
DE102012100780A8 (de) Zugmittelhebevorrichtung
TH1301004215B (th) องค์ประกอบเชิงเภสัชกรรมซึ่งประกอบรวมด้วยอนุพันธ์ไพริโอน